Evaluation of two processes of colon carcinoma in medical oncology;Evaluación de dos procesos de carcinoma de colon en oncología médica

Revista de Calidad Asistencial

Volumn 16, Issue 3, 2001, Pages 183-192

  Grávalos, Cristina ^a   Rodríguez Dapena, Silvia ^a   Alcalde, Juan ^a   Martínez Pueyo, J Ignacio ^a   Castells, Victoria ^a   Ruiz López, Pedro ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Adyuvant Chemotherapy; Colon Carcinoma; Indicators; Management Process; Quality Assessment

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL PROTOCOL; COLON CARCINOMA; DIAGNOSTIC APPROACH ROUTE; EVALUATION; FEMALE; HEALTH CARE QUALITY; HUMAN; ILLNESS BEHAVIOR; INFORMED CONSENT; MALE; PATIENT SELECTION; PHYSICAL EXAMINATION; TREATMENT INDICATION;

EID: 0035709564     PISSN: 1134282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1134-282X(01)77403-9     Document Type: Article

References (22)

1. Quality assurance and medical outcomes in the era of cost containment
2. Proceso de autoevaluación de los centros sanitarios de Osakidetza mediante el modelo europeo de gestión de calidad total
3. Gestión de procesos
4. Gestión por procesos en un equipo de atención primaria
5. ¿Gestión de procesos en asistencia sanitaria?
6. Evaluating health care
7. Estudio del proceso "carcinoma de colon en cirugía programada"
8. Desarrollo de una vía clínica para mejorar el proceso de tratamiento adyuvante del carcinoma de colon
9. Chemotherapy for colorectal cancer
10. Adjuvant therapy for stage III colon cancer: Economic returns to research and cost-effectiveness of treatment
11. The benefit of leucovorinmodulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: Results form National Surgical Adjuvant Breast and Bowel Project protocol C-03
12. An intergroup trial of intensive course 5FU and low dose leucovorin as surgical adjuvant therapy for high risk colon cancer
13. Therapy: State-of-the-art assessment of quality. The National Cancer Institute perspective
14. Recomended colorectal cancer surveillence guidelines by American Society of Clinical Oncology
15. Prospective analysis of severe toxicity associated with 5-FU and leucovorin (Mayo Clinic Regimen) in colorectal cancer patients